908 related articles for article (PubMed ID: 11103818)
21. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
22. Expression of c-kit proto-oncogene product in breast tissue.
Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA
Breast J; 2004; 10(4):323-7. PubMed ID: 15239791
[TBL] [Abstract][Full Text] [Related]
23. KAI1 protein is down-regulated during the progression of human breast cancer.
Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
[TBL] [Abstract][Full Text] [Related]
24. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
25. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
26. Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization.
Campo E; Monteagudo C; Castronovo V; Claysmith AP; Fernandez PL; Sobel ME
Am J Pathol; 1992 Nov; 141(5):1073-83. PubMed ID: 1443045
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
Helczynska K; Kronblad A; Jögi A; Nilsson E; Beckman S; Landberg G; Påhlman S
Cancer Res; 2003 Apr; 63(7):1441-4. PubMed ID: 12670886
[TBL] [Abstract][Full Text] [Related]
28. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
Lawrence JA; Merino MJ; Simpson JF; Manrow RE; Page DL; Steeg PS
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):29-35. PubMed ID: 9456240
[TBL] [Abstract][Full Text] [Related]
29. [Effect of expression of gut-enriched Kruppel-like factor on esophageal squamous cancer cells].
Wang N; Liu ZH; Ding F; Wang XQ; Wu M
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):55-8. PubMed ID: 12518228
[TBL] [Abstract][Full Text] [Related]
30. Loss of USF transcriptional activity in breast cancer cell lines.
Ismail PM; Lu T; Sawadogo M
Oncogene; 1999 Sep; 18(40):5582-91. PubMed ID: 10523835
[TBL] [Abstract][Full Text] [Related]
31. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO
Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454
[TBL] [Abstract][Full Text] [Related]
32. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
33. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade.
Sowter HM; Ferguson M; Pym C; Watson P; Fox SB; Han C; Harris AL
J Pathol; 2003 Dec; 201(4):573-80. PubMed ID: 14648660
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
37. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
38. Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth.
Silberstein GB; Dressler GR; Van Horn K
Oncogene; 2002 Feb; 21(7):1009-16. PubMed ID: 11850818
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression.
Liu XL; Wazer DE; Watanabe K; Band V
Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136
[TBL] [Abstract][Full Text] [Related]
40. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
